Citius Pharmaceuticals, Inc.
Q2 2025 13F Holders
Symbol
CTXR
CUSIP
17322U306
Type
Equity
Class
COM
Num filers
34
Total reported value, excl. options
$1.48 M
Compare 2025 Q2 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type